Measurement of changes in antihypertensive drug utilisation following primary care educational interventions

Pharmacoepidemiology and Drug Safety
Fiona E HornRob J Hyndman

Abstract

To measure changes in drug utilisation following a national general practice education program aimed at improving prescribing for hypertension. A series of nationally implemented, multifaceted educational interventions using social marketing principles focusing on prescribing for hypertension, was commenced in October 1999, and repeated in September 2001 and August 2003. The target group was all primary care prescribers in Australia and interventions were both active (voluntary) and passive. Newsletter and prescribing feedback was mailed in October 1999, September 2001 (newsletter only) and August 2003. Approximately a third of general practitioners (GPs) in Australia undertook at least one active educational activity (clinical audit, educational visit or case study) during the period October 1999-April 2004. National dispensing data from 1996 to 2004 were analysed using time series methodology with a decay term for intervention effect, to assess trends in prescribing of various classes of antihypertensives. In particular, the program aimed to increase the prescribing of thiazide diuretics and beta blockers. Consistent with key intervention messages, the program achieved an increase in low-dose thiazide and beta blocker prescri...Continue Reading

References

Mar 22, 1985·JAMA : the Journal of the American Medical Association·W A RayC F Federspiel
Aug 27, 1999·JAMA : the Journal of the American Medical Association·B M PsatyE H Wagner
Sep 30, 2000·Australian and New Zealand Journal of Public Health·J SimsH Long
Jan 10, 2001·The Medical Journal of Australia·P McManusM E Auland
Feb 24, 2001·Australian and New Zealand Journal of Public Health·N DonnellyW Hall
Jun 12, 2002·The Medical Journal of Australia·Jane RobertsonDavid A Henry
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
Oct 22, 2003·The American Journal of Medicine·Sumit R MajumdarStephen B Soumerai
Nov 5, 2003·Journal of Hypertension·Judith A Whitworth, UNKNOWN World Health Organization, International Society of Hypertension Writing Group
Feb 13, 2004·Health Technology Assessment : HTA·J M GrimshawC Donaldson
Dec 21, 2004·British Journal of Clinical Pharmacology·L M WeekesS R Phillips

❮ Previous
Next ❯

Citations

May 17, 2013·International Journal of Clinical Pharmacy·Svetla GadzhanovaElizabeth E Roughead
Jan 17, 2009·Health Policy·Zoë Slote Morris, Peter John Clarkson
Feb 20, 2009·Internal Medicine Journal·A Vitry, Y H Lai
Dec 22, 2007·Pharmacoepidemiology and Drug Safety·John A MandrykLynn M Weekes
Mar 6, 2009·The Annals of Pharmacotherapy·Remo OstiniSusan E Tett
Oct 1, 2020·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·M J M ValkF H Rutten
Aug 17, 2011·The Medical Journal of Australia·David LimV Bruce Sunderland

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
M SteadL McDermott
© 2022 Meta ULC. All rights reserved